Tony Hu is an associate professor in the School for Biological and Health Systems Engineering and the Biodesign Virginia G. Piper Center for Personalized Diagnostics at Arizona State University. 

Hu's research focuses on developing and validating integrated nanotechnique-based strategies to perform marker discovery and molecular diagnostics from peripheral blood, and to provide a translatable solution for personalized medicine. His group's innovations aim to fill current gaps in real-time therapy monitoring, early detection, and effective prognostics. His team is diverse with backgrounds in biochemistry, mass spectrometry, nanofabrication and biomedical engineering to answer these needs.

Hu's research group has established and refined a biomarker detection platform to quantitate the peptidome of circulating mycobacterial antigen and validate its capacity to diagnose the species of mycobacterial infections and its response to therapeutic intervention. His experience and in-depth understanding of multiplex-detection method development for sample processing, mass spectrometry, biomarker identification and validation ideally positions him in a leading role to ensure optimal progress toward the clinical translation of a platform for improved and comprehensive analysis of blood-based biomarkers of mycobacterial infection, with potentially broad clinical applications.